Community screening of participants across community pharmacies detecting asymptomatic clinical markers or risk factors associated with cardiovascular disease and chronic disease.

Not Applicable

Recruiting

• Conditions: Cardiovascular disease; Metabolic and Endocrine - Diabetes; Cardiovascular - Other cardiovascular diseases; diabetes; High Cholestrol; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12619000405112
• Lead Sponsor: Blackswan Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-13
• Last Update Posted: 3 March 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 2200

Inclusion Criteria

individuals 45-74 years
individuals 35-74 years if Aboriginal or Torres strait Islander
Who are able to make independent decisions regarding their health care
Both Males and Females
Healthy volunteers

Exclusion Criteria

Diagnosed cardiovascular disease or diabetes
Currently being treated for hypertension or lipid disorders
Currently engaged in any lifestyle modification program

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Composite Outcome measure of proportion of screened individuals, identified with disease risk factors.<br>Validated tools and equipment will be used to estimate CVD risk or detect existing or related disease.<br> Ausdrisk score, SF 36 validated quality of life questionnaire. (POC) testing for lipid and HbA1c. Equipment used will be COBAs (POC) machine, BP Omron machine. [Baseline, 6 Month 12 months ]

Secondary Outcome Measures

Name	Time	Method
Percentage of screened participants referred on to primary care services through data linkage of MBS/PBS data consent form and referral medical records.[6 month and 12 month assessment after randomisation/baseline visit.];Quality of life SF 36 validated health survey questionnaire[Baseline, 6 month and 12 month visits.]